J&J vaccine has ‘small possible risk’ of rare neurological disorder, CDC reports
U.S. health officials said Monday Johnson & Johnson’s COVID-19 vaccine may pose a "small possible risk" of a rare neurological disorder known as Guillain-Barré syndrome, another setback for the vaccine that was temporarily paused earlier this year.